Research graph
References from Carbonic anhydrase inhibition rescues heart function in the Tg2576 Alzheimer’s mouse model by ameliorating cardiac amyloid-β pathology and neurotrophic-signaling impairment. Local targets link to admitted publications; unresolved targets remain external evidence.
In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection
10.1016/j.micpath.2022.105454 · 2022 · External reference
10.1517/13543776.2013.782394
10.1517/13543776.2013.782394 · External reference
Obese mice exposed to psychosocial stress display cardiac and hippocampal dysfunction associated with local brain-derived neurotrophic factor depletion
10.1016/j.ebiom.2019.08.042 · 2019 · External reference
10.1038/s41598-024-67638-x
10.1038/s41598-024-67638-x · External reference
10.2174/157015911798376190
10.2174/157015911798376190 · External reference
10.1113/jphysiol.2006.123638
10.1113/jphysiol.2006.123638 · External reference
10.1186/1471-2261-13-2
10.1186/1471-2261-13-2 · External reference
Amyloid Beta Oligomers Activate Death Receptors and Mitochondria-Mediated Apoptotic Pathways in Cerebral Vascular Smooth Muscle Cells; Protective Effects of Carbonic Anhydrase Inhibitors
2023 · External reference
10.1111/j.1471-4159.2007.04704.x
10.1111/j.1471-4159.2007.04704.x · External reference
Diuretic Resistance and Decongestion With Upfront Acetazolamide in Acute Decompensated Heart Failure: The ADVOR Trial
10.1016/j.jchf.2025.102676 · 2025 · External reference
10.1523/jneurosci.23-36-11373.2003
10.1523/jneurosci.23-36-11373.2003 · External reference
Genotype-and sex-specific changes in vital parameters during isoflurane anesthesia in a mouse model of Alzheimer’s disease
2024 · External reference
10.3390/ijms24055004
10.3390/ijms24055004 · External reference
10.1002/alz.13063
10.1002/alz.13063 · External reference
10.1161/circresaha.122.321583
10.1161/circresaha.122.321583 · External reference
10.3389/fphar.2019.00888
10.3389/fphar.2019.00888 · External reference
10.1002/alz.70122
10.1002/alz.70122 · External reference
10.1038/s41598-020-66898-7
10.1038/s41598-020-66898-7 · External reference
10.1161/atvbaha.121.316066
10.1161/atvbaha.121.316066 · External reference
Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice
10.3233/jad-2010-1288 · 2010 · External reference
Reduced slow-wave activity and autonomic dysfunction during sleep precede cognitive deficits in Alzheimer’s disease transgenic mice
10.1038/s41598-023-38214-6 · 2023 · External reference
Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting beta-Catenin Degradation in Type 1 Diabetic Mice
10.2337/db21-0506 · 2022 · External reference
Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome
10.1016/j.freeradbiomed.2017.10.341 · 2018 · External reference
Atrial fibrillation and dementia: not just a coincidence
10.26599/1671-5411.2023.09.003 · 2023 · External reference
10.1016/j.celrep.2025.115408
10.1016/j.celrep.2025.115408 · External reference
10.1016/j.yjmcc.2005.03.003
10.1016/j.yjmcc.2005.03.003 · External reference
10.1161/circheartfailure.117.004153
10.1161/circheartfailure.117.004153 · External reference
10.1093/gerona/gly139
10.1093/gerona/gly139 · External reference
10.3389/fnmol.2023.1163087
10.3389/fnmol.2023.1163087 · External reference
Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions
10.3389/fcvm.2023.1197432 · 2023 · External reference
10.3390/life11111256
10.3390/life11111256 · External reference
10.1038/ng1096-210
10.1038/ng1096-210 · External reference
10.11909/j.issn.1671-5411.2021.07.009
10.11909/j.issn.1671-5411.2021.07.009 · External reference
10.3389/fphys.2023.1060666
10.3389/fphys.2023.1060666 · External reference
10.1002/advs.202511924
10.1002/advs.202511924 · External reference
Amyloid beta Instigates Cardiac Neurotrophic Signaling Impairment, Driving Alzheimer’s Associated Heart Disease
2026 · External reference
The heart-brain crosstalk in age related cardiovascular and neurodegenerative diseases
10.1186/s12987-025-00700-6 · 2025 · External reference
10.1006/mcne.2001.1016
10.1006/mcne.2001.1016 · External reference
10.1073/pnas.1417949112
10.1073/pnas.1417949112 · External reference
10.1016/j.nbd.2015.11.006
10.1016/j.nbd.2015.11.006 · External reference
Efficacy of acetazolamide for the prophylaxis of acute mountain sickness: A systematic review, meta-analysis, and trial sequential analysis of randomized clinical trials
10.4103/atm.atm_651_20 · 2021 · External reference
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
10.1186/s40035-022-00279-0 · 2022 · External reference
Carbonic anhydrase, its inhibitors and vascular function
10.3389/fmolb.2024.1338528 · 2024 · External reference
10.1016/j.jacc.2013.04.004
10.1016/j.jacc.2013.04.004 · External reference
10.1161/circulationaha.109.879510
10.1161/circulationaha.109.879510 · External reference
10.1038/s41582-019-0281-2
10.1038/s41582-019-0281-2 · External reference
10.1038/s41598-020-66009-6
10.1038/s41598-020-66009-6 · External reference
Carbonic anhydrase inhibitors prevent presymptomatic capillary flow disturbances in a model of cerebral amyloidosis
10.1002/alz.70023 · 2025 · External reference
The Emerging Role of BDNF/TrkB Signaling in Cardiovascular Diseases
2021 · External reference
10.1212/wnl.0b013e31828726f5
10.1212/wnl.0b013e31828726f5 · External reference
Carbonic anhydrase, obstructive sleep apnea and hypertension: Effects of intervention
10.1111/jsr.12956 · 2020 · External reference
10.1016/j.amjhyper.2005.09.014
10.1016/j.amjhyper.2005.09.014 · External reference
10.1126/science.274.5284.99
10.1126/science.274.5284.99 · External reference
Acetazolamide improves cerebral hemodynamics in CADASIL
2010 · External reference
10.3390/cells11030454
10.3390/cells11030454 · External reference
10.1186/s13024-017-0231-7
10.1186/s13024-017-0231-7 · External reference
10.1002/ana.78238
10.1002/ana.78238 · External reference
Reduced Cardiovascular Functions in Patients with Alzheimer’s Disease
10.3233/jad-170088 · 2017 · External reference
10.1161/01.cir.0000115516.54550.b1
10.1161/01.cir.0000115516.54550.b1 · External reference
10.1523/jneurosci.21-02-00372.2001
10.1523/jneurosci.21-02-00372.2001 · External reference
10.1002/alz.13512
10.1002/alz.13512 · External reference
10.3389/fphys.2019.00455
10.3389/fphys.2019.00455 · External reference
10.1001/archneur.62.10.1556
10.1001/archneur.62.10.1556 · External reference
10.1016/j.neurobiolaging.2013.02.015
10.1016/j.neurobiolaging.2013.02.015 · External reference
10.1038/srep13313
10.1038/srep13313 · External reference
10.3389/fnagi.2021.772278
10.3389/fnagi.2021.772278 · External reference
10.64898/2026.03.16.711716
10.64898/2026.03.16.711716 · External reference
Ablation of cardiomyocyte-derived BDNF during development causes myocardial degeneration and heart failure in the adult mouse heart
10.3389/fcvm.2022.967463 · 2022 · External reference
10.3390/ijms21176109
10.3390/ijms21176109 · External reference
10.1038/s41589-024-01762-7
10.1038/s41589-024-01762-7 · External reference
10.1093/eurheartj/ehad205
10.1093/eurheartj/ehad205 · External reference
Effects of two different exercise paradigms on cardiac function, BDNF-TrkB expression, and myocardial protection in the presence and absence of Western diet
2022 · External reference
Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial
10.1161/circulationaha.122.062486 · 2023 · External reference
Genetic Catalytic Inactivation of GRK5 Impairs Cardiac Function in Mice Via Dysregulated P53 Levels
10.1016/j.jacbts.2022.01.001 · 2022 · External reference
Alzheimer’s disease
10.1038/nrdp.2015.56 · 2015 · External reference
Circulating Biomarkers in Hypertrophic Cardiomyopathy
10.1161/jaha.122.027618 · 2022 · External reference
Assessing Rodent Cardiac Function in vivo Using Hemodynamic Pressure-Volume Loops
2021 · External reference
10.3389/fncel.2019.00363
10.3389/fncel.2019.00363 · External reference
Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
10.1002/med.21713 · 2020 · External reference
Phosphorylation Modifications Regulating Cardiac Protein Ǫuality Control Mechanisms
10.3389/fphys.2020.593585 · 2020 · External reference
10.1016/s0735-1097(99)00574-4
10.1016/s0735-1097(99)00574-4 · External reference
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload
10.1056/nejmoa2203094 · 2022 · External reference
Beyond the brain: early autonomic dysfunction in Alzheimer’s disease
10.1186/s40478-025-02042-8 · 2025 · External reference
Acetazolamide for Idiopathic Intracranial Hypertension: An Up-to-Date Review in 2025
10.2147/eb.s492845 · 2025 · External reference
10.3390/ijms22115719
10.3390/ijms22115719 · External reference
10.3390/cells10112903
10.3390/cells10112903 · External reference
Development and modeling of cardiac autonomic innervation
10.1038/s44161-025-00746-7 · 2025 · External reference
10.1016/s0002-9440(10)62275-4
10.1016/s0002-9440(10)62275-4 · External reference
10.1084/jem.20011797
10.1084/jem.20011797 · External reference
BDNF - A key player in cardiovascular system
10.1016/j.yjmcc.2017.07.007 · 2017 · External reference
10.3390/ijms20194778
10.3390/ijms20194778 · External reference
Expression and Localization of AbetaPP in SH-SY5Y Cells Depends on Differentiation State
10.3233/jad-201409 · 2021 · External reference
UCP2 modulates cardiomyocyte cell cycle activity, acetyl-CoA, and histone acetylation in response to moderate hypoxia
2022 · External reference
10.1523/jneurosci.3854-05.2006
10.1523/jneurosci.3854-05.2006 · External reference
10.1111/jnc.12383
10.1111/jnc.12383 · External reference
10.1016/j.jchf.2018.10.022
10.1016/j.jchf.2018.10.022 · External reference
10.1016/j.yjmcc.2017.10.006
10.1016/j.yjmcc.2017.10.006 · External reference
10.1038/s41591-024-02977-w
10.1038/s41591-024-02977-w · External reference
10.1590/1980-5764-dn-2023-0012
10.1590/1980-5764-dn-2023-0012 · External reference
10.1111/acel.12787
10.1111/acel.12787 · External reference
10.1523/jneurosci.0350-08.2008
10.1523/jneurosci.0350-08.2008 · External reference
10.1177/13872877261449510
10.1177/13872877261449510 · External reference
10.1136/bjophthalmol-2021-319530
10.1136/bjophthalmol-2021-319530 · External reference
10.1006/geno.2000.6163
10.1006/geno.2000.6163 · External reference
Association between Coronary Heart Disease, Heart Failure, and Risk of Alzheimer’s Disease: A Systematic Review and Meta-Analysis
10.4103/aian.aian_361_23 · 2023 · External reference
Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases
10.1080/13543776.2018.1519023 · 2018 · External reference
10.1007/978-94-007-7359-2_18
10.1007/978-94-007-7359-2_18 · External reference
10.1007/s11906-014-0467-3
10.1007/s11906-014-0467-3 · External reference
10.1016/j.atherosclerosis.2017.11.011
10.1016/j.atherosclerosis.2017.11.011 · External reference
10.1161/jaha.113.000434
10.1161/jaha.113.000434 · External reference
10.1016/j.jacc.2016.08.073
10.1016/j.jacc.2016.08.073 · External reference
10.1161/circresaha.118.313563
10.1161/circresaha.118.313563 · External reference
10.1186/s13024-021-00429-4
10.1186/s13024-021-00429-4 · External reference
10.2146/ajhp170279
10.2146/ajhp170279 · External reference
10.1016/j.yjmcc.2011.12.008
10.1016/j.yjmcc.2011.12.008 · External reference
Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats
10.1016/j.carpath.2016.08.003 · 2016 · External reference
Sex-and APOE-specific transcriptomic drug repurposing identifies four candidate therapeutics for Alzheimer’s disease
10.1002/trc2.70303 · 2026 · External reference
10.1073/pnas.172504199
10.1073/pnas.172504199 · External reference
Bidirectional Crosstalk between the Heart and Brain in Alzheimer’s Disease
2024 · External reference
10.1056/nejmra1106180
10.1056/nejmra1106180 · External reference
10.3389/fnins.2022.925991
10.3389/fnins.2022.925991 · External reference
Clinical Significance of B-type Natriuretic Peptide in Heart Failure
10.15280/jlm.2014.4.1.34 · 2014 · External reference
Carbonic anhydrases as disease markers
10.1080/13543776.2019.1629419 · 2019 · External reference
10.1186/s13024-024-00712-0
10.1186/s13024-024-00712-0 · External reference
